Back

Inhibition of Acyl-CoA: Cholesterol Acyltransferase 1 Promotes Shedding of Soluble TREM2 and LRP1-Dependent Phagocytosis of Amyloid β Protein in Microglia

Hovde, M. J.; Maaser-Hecker, A.; Tanzi, R. E.

2025-06-15 cell biology
10.1101/2025.06.12.659424 bioRxiv
Show abstract

Lipid regulation plays a major role in the pathogenesis of Alzheimers disease (AD). In AD patients and transgenic mice, microglia exhibit increased expression of SOAT1, encoding Acyl-CoA: Cholesterol Acyltransferase 1 (ACAT1), which catalyzes the production of cholesteryl esters in lipid droplets. ACAT1 Inhibition has been reported to reduce {beta}-amyloid pathology. However, the molecular mechanism underlying this effect remains unknown. Here, we show ACAT1 inhibition in mouse and human iPSC- derived microglia upregulates LRP1 levels and shedding of soluble TREM2 (sTREM2) owing to enhanced cleavage of TREM2 by ADAM10/17. Knocking out TREM2 or preventing sTREM2 release abrogated the ability of ACAT1 inhibition to enhance microglial uptake of amyloid {beta} (A{beta}). This could be rescued by the addition of recombinant sTREM2, but only in the presence of LRP1. Collectively, these data indicate ACAT1 inhibition increases microglial uptake of A{beta} in a sTREM2- and LRP1-dependent manner suggesting new avenues for treating and preventing AD.

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.